Hogan Lovells advises Eurazeo in connection with €500m continuation fund vehicle

London, 1 April 2022 – Hogan Lovells has advised Eurazeo Investment Manager in relation to G Square Healthcare Private Equity LLP’s closing of a €500 million continuation fund vehicle in connection with the acquisition of three existing assets from its existing vehicles, G Square Capital I and G Square Capital II.

The continuation fund was led by Eurazeo Investment Manager and Schroders Capital Management (Switzerland) AG with participation from other leading institutional investors including a number of existing investors.

It will allow G Square to wind down G Square Capital I and provide significant liquidity to existing G Square Capital II investors, while providing new and existing investors participating in the continuation fund with the opportunity for additional returns on the next stage of the companies’ growth.

The Hogan Lovells team advising Eurazeo was led by Hogan Lovells’ co-head of the secondaries practice Ed Harris, with support from counsels Hannah Logan, Amelia Stawpert (investment funds) and Natalie Psaila, and associate Ellen Dewhurst.

 


Back To Listing